Operating Lease, Right-of-Use Asset of INTERPACE BIOSCIENCES, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
INTERPACE BIOSCIENCES, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • INTERPACE BIOSCIENCES, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,320,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

INTERPACE BIOSCIENCES, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,320,000 -$212,000 -14% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,420,000 -$215,000 -13% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,518,000 -$238,000 -14% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,613,000 -$251,000 -13% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $1,532,000 -$446,000 -23% 30 Sep 2024 10-K 31 Mar 2025 2024 FY
Q2 2024 $1,635,000 -$455,000 -22% 30 Jun 2024 10-K 31 Mar 2025 2024 FY
Q1 2024 $1,756,000 -$542,000 -24% 31 Mar 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $1,864,000 -$575,000 -24% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,978,000 +$1,111,000 +128% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $2,090,000 -$1,393,000 -40% 30 Jun 2023 10-K 31 Mar 2025 2024 FY
Q1 2023 $2,298,000 -$1,462,000 -39% 31 Mar 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $2,439,000 +$1,155,000 +90% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $867,000 -$3,122,000 -78% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $3,483,000 -$285,000 -7.6% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $3,760,000 -$220,000 -5.5% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $1,284,000 -$3,100,000 -71% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $3,989,000 -$769,000 -16% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $3,768,000 -$1,404,000 -27% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $3,980,000 +$1,169,000 +42% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $4,384,000 +$492,000 +13% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $4,758,000 30 Sep 2020 10-Q 20 Jan 2021 2020 Q3
Q2 2020 $5,172,000 +$2,772,000 +116% 30 Jun 2020 10-Q/A 19 Jan 2021 2020 Q2
Q1 2020 $2,811,000 +$411,000 +17% 31 Mar 2020 10-Q/A 19 Jan 2021 2020 Q1
Q4 2019 $3,892,000 31 Dec 2019 10-K 01 Apr 2021 2020 FY
Q2 2019 $2,400,000 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $2,400,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.